<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for CyberLaw Currents</title>
	<atom:link href="http://www.cyberlawcurrents.com/?feed=comments-rss2" rel="self" type="application/rss+xml" />
	<link>http://www.cyberlawcurrents.com</link>
	<description>A Frankfurt Kurnit Blog About the Law of Doing Business on the Internet</description>
	<lastBuildDate>Tue, 10 Aug 2010 23:28:41 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>Comment on FDA&#8217;s First Facebook Enforcement Action by Twitter Trackbacks for CyberLaw Currents » FDA’s First Facebook Enforcement Action [cyberlawcurrents.com] on Topsy.com</title>
		<link>http://www.cyberlawcurrents.com/?p=1216#comment-37</link>
		<dc:creator>Twitter Trackbacks for CyberLaw Currents » FDA’s First Facebook Enforcement Action [cyberlawcurrents.com] on Topsy.com</dc:creator>
		<pubDate>Tue, 10 Aug 2010 23:28:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=1216#comment-37</guid>
		<description>[...] CyberLaw Currents » FDA’s First Facebook Enforcement Action  cyberlawcurrents.com/?p=1216 &#8211; view page &#8211; cached  In what may signal regulators’ growing focus on advertisers’ use of social media, particularly in regulated industries, on July 29, 2010, the FDA issued its first Facebook-related citation in connection with Novartis’ use of Facebook’s share function on its Tasigna® website. By clicking on the “share” button on the website, consumers could post Novartis-created information about... Read moreIn what may signal regulators’ growing focus on advertisers’ use of social media, particularly in regulated industries, on July 29, 2010, the FDA issued its first Facebook-related citation in connection with Novartis’ use of Facebook’s share function on its Tasigna® website. By clicking on the “share” button on the website, consumers could post Novartis-created information about Tasigna® (“Shared Content”) on their Facebook profile walls, which would then be sent to the consumers’ “friends” via the newsfeed. It also allowed a consumer to send a separate message containing the Shared Content to their “friends” on Facebook. The FDA cited four (4) ways in which the website and the Facebook “share” widget violated the Federal Food, Drug and Cosmetic Act and the FDA implementing regulations: (i) omission of risk information, (ii) broadening of drug indication, (iii) unsubstantiated superiority claims/overstatement of efficacy, and (iv) failure to submit. View page    Tweets about this link [...]</description>
		<content:encoded><![CDATA[<p>[...] CyberLaw Currents » FDA’s First Facebook Enforcement Action  cyberlawcurrents.com/?p=1216 &ndash; view page &ndash; cached  In what may signal regulators’ growing focus on advertisers’ use of social media, particularly in regulated industries, on July 29, 2010, the FDA issued its first Facebook-related citation in connection with Novartis’ use of Facebook’s share function on its Tasigna® website. By clicking on the “share” button on the website, consumers could post Novartis-created information about&#8230; Read moreIn what may signal regulators’ growing focus on advertisers’ use of social media, particularly in regulated industries, on July 29, 2010, the FDA issued its first Facebook-related citation in connection with Novartis’ use of Facebook’s share function on its Tasigna® website. By clicking on the “share” button on the website, consumers could post Novartis-created information about Tasigna® (“Shared Content”) on their Facebook profile walls, which would then be sent to the consumers’ “friends” via the newsfeed. It also allowed a consumer to send a separate message containing the Shared Content to their “friends” on Facebook. The FDA cited four (4) ways in which the website and the Facebook “share” widget violated the Federal Food, Drug and Cosmetic Act and the FDA implementing regulations: (i) omission of risk information, (ii) broadening of drug indication, (iii) unsubstantiated superiority claims/overstatement of efficacy, and (iv) failure to submit. View page    Tweets about this link [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Techonomy Conference Update by AP Exclusive: Angle outlines views on gays, clergy North Capitol Street</title>
		<link>http://www.cyberlawcurrents.com/?p=1210#comment-35</link>
		<dc:creator>AP Exclusive: Angle outlines views on gays, clergy North Capitol Street</dc:creator>
		<pubDate>Thu, 05 Aug 2010 21:30:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=1210#comment-35</guid>
		<description>[...] CyberLaw Currents » Techonomy Conference Update [...]</description>
		<content:encoded><![CDATA[<p>[...] CyberLaw Currents » Techonomy Conference Update [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Chinese Search Engine Suit Proceeds Against Register.com by Super Call Saver Telecommunications Savings Portal &#187; Blog Archive &#187; Baidu response to the mobile market</title>
		<link>http://www.cyberlawcurrents.com/?p=1187#comment-34</link>
		<dc:creator>Super Call Saver Telecommunications Savings Portal &#187; Blog Archive &#187; Baidu response to the mobile market</dc:creator>
		<pubDate>Mon, 02 Aug 2010 22:20:43 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=1187#comment-34</guid>
		<description>[...] CyberLaw Currents &#187; Chinese Search Engine Suit Proceeds Against Register.com [...]</description>
		<content:encoded><![CDATA[<p>[...] CyberLaw Currents &raquo; Chinese Search Engine Suit Proceeds Against Register.com [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Chinese Search Engine Suit Proceeds Against Register.com by April 1st Release Date: &#8220;If I Can Hold Your Hand&#8221; &#8211; a song to help save Taylor&#8217;s life &#124; HealthClean.net</title>
		<link>http://www.cyberlawcurrents.com/?p=1187#comment-33</link>
		<dc:creator>April 1st Release Date: &#8220;If I Can Hold Your Hand&#8221; &#8211; a song to help save Taylor&#8217;s life &#124; HealthClean.net</dc:creator>
		<pubDate>Sat, 31 Jul 2010 11:52:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=1187#comment-33</guid>
		<description>[...] CyberLaw Currents &#187; Chinese Search Engine Suit Proceeds Against Register.com [...]</description>
		<content:encoded><![CDATA[<p>[...] CyberLaw Currents &raquo; Chinese Search Engine Suit Proceeds Against Register.com [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Chinese Search Engine Suit Proceeds Against Register.com by CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230; Consolidations on me</title>
		<link>http://www.cyberlawcurrents.com/?p=1187#comment-32</link>
		<dc:creator>CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230; Consolidations on me</dc:creator>
		<pubDate>Tue, 27 Jul 2010 23:10:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=1187#comment-32</guid>
		<description>[...] the rest here:  CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230;          By admin &#124; category: company name register &#124; tags: denny, did-not, district, domain, [...]</description>
		<content:encoded><![CDATA[<p>[...] the rest here:  CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230;          By admin | category: company name register | tags: denny, did-not, district, domain, [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Chinese Search Engine Suit Proceeds Against Register.com by CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230; Cable Body</title>
		<link>http://www.cyberlawcurrents.com/?p=1187#comment-31</link>
		<dc:creator>CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230; Cable Body</dc:creator>
		<pubDate>Tue, 27 Jul 2010 17:48:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=1187#comment-31</guid>
		<description>[...] here:  CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230;          By admin &#124; category: company register &#124; tags: denny, did-not, district, district-court, [...]</description>
		<content:encoded><![CDATA[<p>[...] here:  CyberLaw Currents » Chinese Search Engine Suit Proceeds Against &#8230;          By admin | category: company register | tags: denny, did-not, district, district-court, [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Facebook: 5,830; US Constitution: 4,543 by GERALD</title>
		<link>http://www.cyberlawcurrents.com/?p=979#comment-30</link>
		<dc:creator>GERALD</dc:creator>
		<pubDate>Mon, 05 Jul 2010 13:04:23 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=979#comment-30</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://pillspot.org/&quot; rel=&quot;nofollow&quot;&gt;Pillspot.org. Canadian Health&amp;Care.Special Internet Prices.No prescription online pharmacy.Best quality drugs. No prescription pills. Order drugs online&lt;/a&gt;...&lt;/strong&gt;

Buy:Zocor.Benicar.Ventolin.Lipothin.Zetia.Lasix.Nymphomax.Seroquel.Prozac.Aricept.Amoxicillin.Lipitor.Female Cialis.Buspar.Cozaar.Advair.Female Pink Viagra.Wellbutrin SR.SleepWell.Acomplia....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://pillspot.org/" rel="nofollow">Pillspot.org. Canadian Health&amp;Care.Special Internet Prices.No prescription online pharmacy.Best quality drugs. No prescription pills. Order drugs online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Zocor.Benicar.Ventolin.Lipothin.Zetia.Lasix.Nymphomax.Seroquel.Prozac.Aricept.Amoxicillin.Lipitor.Female Cialis.Buspar.Cozaar.Advair.Female Pink Viagra.Wellbutrin SR.SleepWell.Acomplia&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on FTC Approves Google Purchase of AdMob by CHRISTIAN</title>
		<link>http://www.cyberlawcurrents.com/?p=993#comment-29</link>
		<dc:creator>CHRISTIAN</dc:creator>
		<pubDate>Wed, 30 Jun 2010 04:15:13 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=993#comment-29</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://pillspot.org/&quot; rel=&quot;nofollow&quot;&gt;Pillspot.org. Canadian Health&amp;Care.No prescription online pharmacy.Best quality drugs.Special Internet Prices. No prescription drugs. Order drugs online&lt;/a&gt;...&lt;/strong&gt;

Buy:Lipitor.Prozac.Zocor.Benicar.Nymphomax.Advair.SleepWell.Seroquel.Amoxicillin.Buspar.Cozaar.Female Pink Viagra.Wellbutrin SR.Lipothin.Aricept.Female Cialis.Acomplia.Ventolin.Zetia.Lasix....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://pillspot.org/" rel="nofollow">Pillspot.org. Canadian Health&amp;Care.No prescription online pharmacy.Best quality drugs.Special Internet Prices. No prescription drugs. Order drugs online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Lipitor.Prozac.Zocor.Benicar.Nymphomax.Advair.SleepWell.Seroquel.Amoxicillin.Buspar.Cozaar.Female Pink Viagra.Wellbutrin SR.Lipothin.Aricept.Female Cialis.Acomplia.Ventolin.Zetia.Lasix&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on $12MM Fine for Failure to Follow Privacy Policy by CyberLaw Currents &#187; FTC Settles Charges Against Twitter</title>
		<link>http://www.cyberlawcurrents.com/?p=921#comment-28</link>
		<dc:creator>CyberLaw Currents &#187; FTC Settles Charges Against Twitter</dc:creator>
		<pubDate>Mon, 28 Jun 2010 21:03:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=921#comment-28</guid>
		<description>[...] If you promise customers that their personal information is secure, you had better deliver on that promise. That is the message of last week&#8217;s settlement between the FTC and Twitter &#8212; the FTC&#8217;s first case against a social networking service. It&#8217;s a message the FTC has sent to industry before. [...]</description>
		<content:encoded><![CDATA[<p>[...] If you promise customers that their personal information is secure, you had better deliver on that promise. That is the message of last week&#8217;s settlement between the FTC and Twitter &#8212; the FTC&#8217;s first case against a social networking service. It&#8217;s a message the FTC has sent to industry before. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on News Bits by MARSHALL</title>
		<link>http://www.cyberlawcurrents.com/?p=973#comment-27</link>
		<dc:creator>MARSHALL</dc:creator>
		<pubDate>Sat, 26 Jun 2010 13:03:45 +0000</pubDate>
		<guid isPermaLink="false">http://www.cyberlawcurrents.com/?p=973#comment-27</guid>
		<description>&lt;strong&gt;PillSpot.org. Canadian Health&amp;Care.No prescription online pharmacy.Special Internet Prices.PillSpot.org.&lt;b&gt; &lt;a href=&quot;http://pillspot.org/products/vitamins_herbal_supplements/ Herbal-supplements@buy.online&quot; rel=&quot;nofollow&quot;&gt;.&lt;/a&gt;...&lt;/strong&gt;

Categories: &lt;b&gt;Blood Pressure/Heart.Womens Health.Antiviral.Antidiabetic.Stomach.Anxiety/Sleep Aid.Mens Health.Anti-allergic/Asthma.Antidepressants.Eye Care.Mental HealthPain Relief.Stop SmokingAntibiotics.Weight Loss.Vitamins/Herbal Supplements.Skin...</description>
		<content:encoded><![CDATA[<p><strong>PillSpot.org. Canadian Health&amp;Care.No prescription online pharmacy.Special Internet Prices.PillSpot.org.<b> <a href="http://pillspot.org/products/vitamins_herbal_supplements/ <a href="mailto:Herbal-supplements@buy.online">Herbal-supplements@buy.online</a>&#8221; rel=&#8221;nofollow&#8221;>.&#8230;</b></strong></p>
<p>Categories: <b>Blood Pressure/Heart.Womens Health.Antiviral.Antidiabetic.Stomach.Anxiety/Sleep Aid.Mens Health.Anti-allergic/Asthma.Antidepressants.Eye Care.Mental HealthPain Relief.Stop SmokingAntibiotics.Weight Loss.Vitamins/Herbal Supplements.Skin&#8230;</b></p>
]]></content:encoded>
	</item>
</channel>
</rss>
